Clinical Trials for Eltrombopag

2 Open Trials

Trial TypeProtocol No. &
Open Date
Supportive CarePRECOGHEM0901
Phase I Dose Finding/Phase II Placebo-Controlled Trial of Eltrombopag During Consolidation Therapy in Adults with Acute Myeloid Leukemia (AML) in Complete Remission
A Randomized, Blinded, Placebo-Controlled, Dose Finding Study to Assess the Safety and Efficacy of the Oral Thrombopoietin Receptor Agonist, Eltrombopag, Administered to Subjects with Acute Myelogenous Leukaemia (AML) Receiving Induction Chemotherapy

Back to Find By Drug

You do not have JavaScript enabled. This site works better with JavaScript turned on.